Bifidobacterium animalis subsp. lactis BB-12 and Improved Effectiveness in Inflammatory Bowel Disease

• Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management.

  • 2025-09-17
  • Review
  • International journal of molecular sciences 26(18)
  • • Emília Hijová

  • PubMed: 41009629
  • DOI: 10.3390/ijms26189065

  8 Insights on

  • Improved Effectiveness in Inflammatory Bowel Disease

  • Moderate evidence
  • Rigorous Journal

  This review summarizes human randomized clinical trials that evaluate the usefulness of various probiotics in relation to the treatment, prevention, and maintenance of disease remission.

  Effect

  Beneficial

  Effect size

  Small

• Microbial modulators of the epigenome: probiotic regulation of MiRNAs and LncRNAs in health and disease and preventive medicine.

  • 2026-01-07
  • Review
  • Gut pathogens 18(1)
  • • Shanshan Xie
    • Yong Zhi
    • Bita Badehnoosh

  • PubMed: 41495822
  • DOI: 10.1186/s13099-025-00789-y

  3 Insights on

  • Improved Effectiveness in Inflammatory Bowel Disease

  • Low evidence

  Special emphasis is placed on disease models including inflammatory bowel disease, colorectal cancer, metabolic syndrome and Alzheimer's disease, highlighting the beneficial possible of targeting the gut microbiota-ncRNA axis.

  Effect

  Beneficial

  Effect size

  Moderate